RR

Rizwanur Rahim

Active Director Director DIN 07304744
DIN 07304744 First appointment Nov 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2015
Shareholding value •••• Premium profile

About Rizwanur Rahim

Data last updated:

Rizwanur Rahim is a Director at Rizm Laboratories Private Limited (since 2015). The company operates in Healthcare. Rizm Laboratories Private Limited reported revenue of ₹32.4 Lakh (FY 2025).

DIN 07304744
Primary Designation Director
Industry Healthcare
First Appointment 30 Nov 2015
Oldest Company Age 10 yrs
Largest company Rizm Laboratories Private Limited · ₹32.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rizm Laboratories Private Limited U24200MH2015PTC270548
Director30 Nov 20152015₹32.4 Lakh (FY 2025)Active

Board colleagues of Rizwanur Rahim

Directorship timeline

Open interactive timeline →
Rizm Laboratories Private Limited
Premium access

Shareholding and investment profile for Rizwanur Rahim

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rizwanur Rahim

Rizwanur Rahim currently holds 1 directorship: Rizm Laboratories Private Limited (Director, since 30 Nov 2015, revenue ₹32.4 Lakh (FY 2025)).

Rizwanur Rahim was first appointed on 30 Nov 2015 as Director at Rizm Laboratories Private Limited.

The current boards of Rizwanur Rahim's companies include Mohammed Mujahid Haji Abdul Kalam Ahmad (Rizm Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available